Antiretroviral drug resistance among drug-naive HIV-1 infected patients

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Korean Journal of Internal Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Update of the Drug Resistance Mutations in HIV-1.

  2008cited by this paper
• The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy

  2006cited by this paper
• Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

  2006cited by this paper
• Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

  2005cited by this paper
• Update of the drug resistance mutations in HIV-1: Fall 2005.

  2005cited by this paper
• Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis.

  2005cited by this paper
• Management of Newly Diagnosed HIV Infection

  2005cited by this paper
• Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

  2005cited by this paper
• Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

  2005cited by this paper
• Stability of transmitted drug-resistant HIV-1 species

  2005cited by this paper
• The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.

  2004cited by this paper
• Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy.

  2004cited by this paper
• Transmission of HIV-1 drug resistance.

  2004cited by this paper
• Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.

  2004cited by this paper
• Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

  2003cited by this paper
• Genotypic Resistance of Antiretroviral Drugs among Drug-Naive HIV Type 1 Patients with the Background of Long-Term Access-Easy Zidovudine Therapy

  2003cited by this paper
• Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

  2002cited by this paper
• Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation

  2002cited by this paper
• Antiretroviral-drug resistance among patients recently infected with HIV.

  2002cited by this paper
• Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance

  2002cited by this paper
• Time trends in primary HIV-1 drug resistance among recently infected persons.

  2002cited by this paper
• Use of Genotypic Resistance Testing To Guide HIV Therapy: Clinical Impact and Cost-Effectiveness

  2001cited by this paper
• Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease

  2001cited by this paper
• Establishment of New Transmissible and Drug-Sensitive Human Immunodeficiency Virus Type 1 Wild Types due to Transmission of Nucleoside Analogue-Resistant Virus

  2001cited by this paper
• Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998.

  2000cited by this paper
• HIV-1 drug resistance in newly infected individuals.

  1999cited by this paper
• Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.

  1999cited by this paper
• Transmission of antiretroviral-drug-resistant HIV-1 variants.

  1999cited by this paper
• Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

  1999cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Induction of specific T‐cell responses in HIV infection

  1998cited by this paper

• Resistance Trends of Antiretroviral Agents in People with Human Immunodeficiency Virus in Korea, 2012 - 2020

  2023cites this paper
• The 2018 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans

  2019cites this paper
• Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea.

  2015cites this paper
• The 2013 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans

  2013cites this paper
• The 2015 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans

  2011cites this paper
• PrimaryAnti-retroviralResistanceinTreatment-naiveHIV-infectedPatients: AKoreanHIV/AIDSCohortStudy

  2009cites this paper
• Primary Anti-retroviral Resistance in Treatment-naive HIV-infected Patients: A Korean HIV/AIDS Cohort Study

  2009cites this paper
• Antiretroviral Genotypic Resistance Mutations in HIV-1 Infected Korean Patients with Virologic Failure

  2009influential citation